References
- Fattoum S, Abbes S. Some data on the epidemiology of hemoglobinopathies in Tunisia. Hemoglobin 1985; 9(4)423–429
- Chibani J, Vidaud M, Duquesnoy P, Berge‐Lefranc J L, Pirastu M, Ellouze F, Rosa J, Goossens M. The peculiar spectrum of β‐thalassemia genes in Tunisia. Hum Genet 1988; 78(2)190–192
- Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of β‐like globin genes. Hemoglobin 1982; 6(1)27–36
- Cai S P, Wall J, Kan Y W, Chehab F F. Reverse dot blot probes for the screening of β‐thalassemia mutations in Asians and American blacks. Hum Mutat 1994; 3(1)59–63
- Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, Goossens M. A comprehensive scanning method for rapid detection of β‐globin gene mutations and polymorphisms. Hum Mutat 1992; 1(3)229–239
- Fattoum S, Guemira F, Oner C, Oner R, Li H‐W, Kutlar F, Huisman T HJ. β‐Thalassemia, Hb S‐β‐thalassemia and sickle cell anemia among Tunisians. Hemoglobin 1991; 15(1)11–21
- Laradi S, Haj K A, Omri H, Chaieb A, Mahjoub T, Benlimam H, Amri F, Saad A, Miled A, Leturcq F, Ben Chibani J, Beldjord C. Molecular analysis and prenatal diagnosis of β‐thalassemia: about our experience in central Tunisia. Ann Biol Clin (Paris) 2000; 58(4)453–460
- Lemsaddek W, Picanco I, Scuanes F, Mahmal L, Benchekroun S, Khattab M, Nogueira P, Osorio‐Almeida L. Spectrum of β‐thalassemia mutations and Hb F levels in the heterozygous Moroccan population. Am J Hematol 2003; 73(3)161–168
- Bennani C, Tamouza R, Rouabhi F, Benabadji M, Malou M, Elion J, Labie D, Beldjord C. The spectrum of β‐thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol 1993; 84(2)335–337
- Waye J S, Borys S, Eng B, Patterson M, Chui D HK, Badr El‐Din O M, Khairy Aref M, Afify Z. Spectrum of β‐thalassemia mutations in Egypt. Hemoglobin 1999; 23(3)255–261
- Zahed L, Qatanani M, Nabulsi M, Taher A. β‐Thalassemia mutations and haplotype analysis in Lebanon. Hemoglobin 2000; 24(4)269–276
- Abd‐el‐latif M, Filon D, Rund D, Oppenheim A, Kanaan M. The β+‐IVS‐I‐6 (T→C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin 2002; 26(1)33–40
- Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M. Molecular characterization of β‐thalassemia in Syria. Hemoglobin 2000; 24(1)1–13
- Cürük M A, Arpaci A, Attila G, Tuli A, Kilinç Y, Aksoy K, Yüregir G T. Genetic heterogeneity of β‐thalassemia at Çukurova in southern Turkey. Hemoglobin 2001; 25(2)241–245
- Cao A, Goossens M, Pirastu M. β‐Thalassemia mutations in Mediterranean populations. Br J Haematol 1989; 71(3)309–312
- Schiliro G, Mirabile E, Testa R, Russo‐Mancuso G, Dibenedetto S P. Presence of hemoglobinopathies in Sicily: a historic perspective. Am J Med Genet 1997; 69(2)200–206
- Rosatelli M C, Dozy A, Faa V, Meloni A, Sardu R, Saba L, Kan Y W, Cao A. Molecular characterization of β‐thalassemia in the Sardinian population. Am J Hum Genet 1992; 50(2)422–426
- Varesi L, Vona G, Memmi M, Marongiu F, Ristaldi M S. β‐Thalassemia mutations in Corsica. Hemoglobin 2000; 24(3)239–244
- Villegas A, Ropero P, Gonzalez F A, Anguita E, Espinos D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin 2001; 25(3)273–283
- Kattamis C, Kattamis A C. Genotypes and phenotypes of β‐thalassemia in Mediterranean populations. Pediatr Hematol Oncol 1997; 14(3)7–16
- Forget B G. Molecular mechanisms of β thalassemia. Disorders of Hemoglobin, Genetics, Pathophysiology, and Clinical Management, M H Steinberg, B G Forget, D R Higgs, R L Nagel. Cambridge University Press, Cambridge 2001; 252–276
- Bennani C, Bouhass R, Perrin‐Pecontal P, Tamouza R, Malou M, Elion J, Trabuchet G, Beldjord C, Benabadji M, Labie D. Anthropological approach to the heterogeneity of β‐thalassemia mutations in northern Africa. Hum Biol 1994; 66(3)369–382
- Zahed L, Demont J, Bouhass R, Trabuchet G, Hanni C, Zalouaa P, Perrin P. Origin and history of the IVSI‐110 and codon 39 β‐thalassemia mutations in the Lebanese population. Hum Biol 2002; 74(6)837–847
- Haj Khelil A, Chebil‐Laradi S, Demont J, Omri H, Chekir‐Ghedira L, Miled A, Chibani J, Perrin‐Pecontal P. Exploration moléculaire de la globine humaine: spplication à l'amélioration de la thérapeutique des hémoglobinopathies et à la recherche de l'origine des mutations. Arab J Pharm Sci 2001; 1(9)5–14